LAI, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 808
EU - Europa 451
AS - Asia 88
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.354
Nazione #
US - Stati Uniti d'America 806
IT - Italia 207
SE - Svezia 70
UA - Ucraina 69
IE - Irlanda 40
VN - Vietnam 35
DE - Germania 31
TR - Turchia 29
CN - Cina 17
FI - Finlandia 17
GB - Regno Unito 8
AT - Austria 2
CA - Canada 2
CL - Cile 2
EU - Europa 2
FR - Francia 2
IN - India 2
MY - Malesia 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
IQ - Iraq 1
JP - Giappone 1
PE - Perù 1
SG - Singapore 1
Totale 1.354
Città #
Milan 142
Fairfield 103
Chandler 92
Ashburn 77
Houston 67
Woodbridge 63
Jacksonville 54
Wilmington 52
Nyköping 38
Seattle 38
Dublin 36
Cambridge 32
Dearborn 32
Princeton 25
San Diego 15
Dong Ket 13
Izmir 12
Ann Arbor 11
Como 10
Rome 8
New York 7
Washington 7
Düsseldorf 6
San Mateo 6
Falls Church 5
Ogden 5
Kunming 3
Piacenza 3
Redmond 3
Varese 3
Boardman 2
Fiano Romano 2
Frankfurt am Main 2
Hefei 2
Helsinki 2
Kuala Lumpur 2
London 2
Norwalk 2
Opera 2
Toronto 2
Vienna 2
Acton 1
Aigaleo 1
Beachwood 1
Beijing 1
Berlin 1
Changsha 1
Chengdu 1
Chicago 1
Cork 1
Dallas 1
Dayville 1
East Brunswick 1
Forte dei Marmi 1
Gulfport 1
Hebei 1
Hounslow 1
Jinan 1
Kilburn 1
La Canada Flintridge 1
Lima 1
Melbourne 1
Mountain View 1
Nanjing 1
Pavia 1
Prague 1
Redwood City 1
Rozzano 1
San Francisco 1
Shenyang 1
Singapore 1
São Paulo 1
Verona 1
Vicenza 1
Xian 1
Totale 1.024
Nome #
Masked hypertension in newly diagnosed hypothyroidism: a pilot study 170
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study 146
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction 140
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose? 129
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center 127
Thyroid autoimmunity and environment 112
An update on the pharmacological management of hyperthyroidism due to Graves' disease 111
Novel treatment modalities for Graves' orbitopathy 103
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 66
Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy 64
Le malattie della tiroide 58
Perspective in pharmacological management of Graves' hyperthyroidism and orbitopathy 45
Quale trattamento attuare per l’ipertiroidismo nei pazienti con orbitopatia basedowiana? 42
The old and the new in subacute thyroiditis: an integrative review 26
UN CASO DI ORBITOPATIA BASEDOWIANA GRAVISSIMA AD ESORDIO IMPROVVISO CON OTTIMA RISPOSTA ALLA TERAPIA MEDICA. 16
DIAGNOSI E TRATTAMENTO DELLA TIREOTOSSICOSI INDOTTA DA AMIODARONE (AIT): DIFFERENZE ED ANALOGIE TRA AMERICAN THYROID ASSOCIATION (ATA) ED EUROPEAN THYROID ASSOCIATION (ETA) 10
Regulatory T cells in the pathogenesis of graves' disease 8
Thyroid Dysfunction in Pregnancy and Postpartum 6
Totale 1.379
Categoria #
all - tutte 5.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201969 0 0 0 0 0 0 0 0 0 11 25 33
2019/2020257 10 7 15 40 26 36 37 31 21 16 5 13
2020/2021183 4 16 5 17 6 14 12 17 36 6 20 30
2021/2022194 26 13 6 7 12 10 32 10 24 34 5 15
2022/2023269 30 22 24 21 14 60 1 35 37 7 7 11
2023/2024295 39 34 41 60 65 38 1 9 8 0 0 0
Totale 1.379